238 related articles for article (PubMed ID: 24598722)
1. Engineering of Escherichia coli strains for plasmid biopharmaceutical production: scale-up challenges.
Gonçalves GA; Prather KL; Monteiro GA; Prazeres DM
Vaccine; 2014 May; 32(24):2847-50. PubMed ID: 24598722
[TBL] [Abstract][Full Text] [Related]
2. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing.
Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM
J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846
[TBL] [Abstract][Full Text] [Related]
3. Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.
Borja GM; Meza Mora E; Barrón B; Gosset G; Ramírez OT; Lara AR
Microb Cell Fact; 2012 Sep; 11():132. PubMed ID: 22992433
[TBL] [Abstract][Full Text] [Related]
4. Effects of fermentation strategy on the characteristics of plasmid DNA production.
O'Kennedy RD; Ward JM; Keshavarz-Moore E
Biotechnol Appl Biochem; 2003 Feb; 37(Pt 1):83-90. PubMed ID: 12578555
[TBL] [Abstract][Full Text] [Related]
5. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha).
Phue JN; Lee SJ; Trinh L; Shiloach J
Biotechnol Bioeng; 2008 Nov; 101(4):831-6. PubMed ID: 18814292
[TBL] [Abstract][Full Text] [Related]
6. Enhanced plasmid DNA production by enzyme-controlled glucose release and an engineered Escherichia coli.
Ramírez EA; Velázquez D; Lara AR
Biotechnol Lett; 2016 Apr; 38(4):651-7. PubMed ID: 26696535
[TBL] [Abstract][Full Text] [Related]
7. De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production.
Gonçalves GA; Prazeres DM; Monteiro GA; Prather KL
Appl Microbiol Biotechnol; 2013 Jan; 97(2):611-20. PubMed ID: 22885693
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of plasmid DNA yields during fed-batch culture of a fruR-knockout Escherichia coli strain.
Ow DS; Yap MG; Oh SK
Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):53-9. PubMed ID: 18380624
[TBL] [Abstract][Full Text] [Related]
9. Kinetic modeling of plasmid bioproduction in Escherichia coli DH5α cultures over different carbon-source compositions.
Lopes MB; Martins G; Calado CR
J Biotechnol; 2014 Sep; 186():38-48. PubMed ID: 24998768
[TBL] [Abstract][Full Text] [Related]
10. Developing strategies to increase plasmid DNA production in Escherichia coli DH5α using batch culture.
Islas-Lugo F; Vega-Estrada J; Alvis CA; Ortega-López J; Del Carmen Montes-Horcasitas M
J Biotechnol; 2016 Sep; 233():66-73. PubMed ID: 27374404
[TBL] [Abstract][Full Text] [Related]
11. Large-scale plasmid preparation for transient gene expression.
Cheng L; Sun X; Yi X; Zhang Y
Biotechnol Lett; 2011 Aug; 33(8):1559-64. PubMed ID: 21476094
[TBL] [Abstract][Full Text] [Related]
12. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
Gonçalves GA; Bower DM; Prazeres DM; Monteiro GA; Prather KL
Biotechnol J; 2012 Feb; 7(2):251-61. PubMed ID: 21913330
[TBL] [Abstract][Full Text] [Related]
13. Engineering of bacterial strains and vectors for the production of plasmid DNA.
Bower DM; Prather KL
Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
[TBL] [Abstract][Full Text] [Related]
14. Development of scale-down techniques for investigation of recombinant Escherichia coli fermentations: acid metabolites in shake flasks and stirred bioreactors.
Dahlgren ME; Powell AL; Greasham RL; George HA
Biotechnol Prog; 1993; 9(6):580-6. PubMed ID: 7764346
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Biosynthesis of Plasmid DNA from Escherichia coli Applying Experimental Design.
Passarinha LA
Methods Mol Biol; 2021; 2197():135-150. PubMed ID: 32827135
[TBL] [Abstract][Full Text] [Related]
16. Physiological effects of pH gradients on Escherichia coli during plasmid DNA production.
Cortés JT; Flores N; Bolívar F; Lara AR; Ramírez OT
Biotechnol Bioeng; 2016 Mar; 113(3):598-611. PubMed ID: 26301871
[TBL] [Abstract][Full Text] [Related]
17. Development of a fed-batch fermentation process to overproduce phosphoenolpyruvate carboxykinase using an expression vector with promoter and plasmid copy number controllable by heat.
Chao YP; Chern JT; Lin WS; Wang ZW
Biotechnol Bioeng; 2003 Nov; 84(4):459-66. PubMed ID: 14574704
[TBL] [Abstract][Full Text] [Related]
18. Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production.
Munguía-Soto R; García-Rendón A; Garibay-Escobar A; Guerrero-Germán P; Tejeda-Mansir A
Biotechnol Appl Biochem; 2015; 62(6):795-805. PubMed ID: 25556882
[TBL] [Abstract][Full Text] [Related]
19. Advances in host and vector development for the production of plasmid DNA vaccines.
Mairhofer J; Lara AR
Methods Mol Biol; 2014; 1139():505-41. PubMed ID: 24619702
[TBL] [Abstract][Full Text] [Related]
20. Scale-up bioprocess development for production of the antibiotic valinomycin in Escherichia coli based on consistent fed-batch cultivations.
Li J; Jaitzig J; Lu P; Süssmuth RD; Neubauer P
Microb Cell Fact; 2015 Jun; 14():83. PubMed ID: 26063334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
